{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-005473","form_type":"8-K","ticker":"STE","cik":"0001757898","company_name":"STERIS plc","filed_at":"2026-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.090080+00:00","generated_at":"2026-05-16T04:58:54.973548+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"STERIS Q3 revenue +9% to $1.5B; adj EPS $2.53 beats prior year $2.32; FY2026 outlook maintained","bullets":["Revenue $1.5B (+9% YoY); constant currency organic revenue growth 8%.","Reported EPS from cont ops $1.96; adjusted EPS $2.53 vs $2.32 last year.","Healthcare revenue $1.1B (+9%), AST $286.6M (+11%), Life Sciences $145.8M (+7%).","Free cash flow first 9 months $737.6M vs $588.1M prior year period.","FY2026 adj EPS guidance reaffirmed $10.15-10.30; tariff headwind increased to ~$55M."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-005473","json":"https://secwatch.observer/filing/0001628280-26-005473.json","markdown":"https://secwatch.observer/filing/0001628280-26-005473.md","text":"https://secwatch.observer/filing/0001628280-26-005473.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757898/000162828026005473/0001628280-26-005473-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757898/000162828026005473/ste-20260204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:58:54.973548+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}